Results 151 to 160 of about 28,321 (229)

Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications. [PDF]

J Clin Med
Krecak I, Lekovic D, Arsenovic I, Dabcevic N, Ivankovic I, Holik H, Zekanovic I, Moric Peric M, Matic AA, Bogdanovic A, Skelin M, Lucijanic M.   +11 more
europepmc   +1 more source

Efficacy and safety of ropeginterferon alfa-2b in the treatment of polycythemia vera: a systematic review with single arm meta-analysis. [PDF]

Ann Hematol
Nada EA, Elfagieh MA, Abdelsalam F, Elrashedy AA, Idres FA, Shata A, Othman AM, Hamoud HMM, Awadalla RM, Qutob IA, Hamed BM.   +10 more
europepmc   +1 more source

DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera. [PDF]

Blood
Abu-Zeinah G, Erdos K, Lee N, Ganom Y, Klade C, Krejcy K, Gisslinger H, Silver RT, Scandura JM.   +8 more
europepmc   +1 more source

Driver mutations (V617FW515L/K or ), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera [PDF]

core   +1 more source

The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis [PDF]

Boque, Concepción, Gómez, Montse, Hernández Boluda, Juan Carlos, Luño Fernández, Elisa, Pereira, Arturo   +4 more
core   +1 more source

A molecular signature predicts hematologic evolution in polycythemia vera patients. [PDF]

Leukemia
Mansier O, Lippert E, Benajiba L, Ranta D, Girodon F, Ianotto JC, Chauveau A, Roy L, Boyer F, Médiavilla C, Tavitian S, Divoux M, Fanet M, Sloma I, De Mas V, Denis G, Nunes Gomes C, Calmettes C, Barraco F, Huet S, Vacheret F, Mercier M, Parry A, Legros L, Soret-Dulphy J, Argentin J, Sureau L, Verger E, Orvain C, Riou J, Kiladjian JJ, Cassinat B, Ugo V, Luque Paz D, French Intergroup of Myeloproliferative Neoplasms (FIM).   +34 more
europepmc   +1 more source

Diagnosis and Treatment of Polycythemia Vera: A Review. [PDF]

JAMA
Tremblay D, Kremyanskaya M, Mascarenhas J, Hoffman R.   +3 more
europepmc   +1 more source

Results from a US modified Delphi consensus to define disease progression and disease modification in polycythemia Vera. [PDF]

Ann Hematol
Bose P, Nagler E, Nawaz MS, Rampal RK, Tashi T, Thota S, Mascarenhas JO.   +6 more
europepmc   +1 more source

Oral Hairy Leukoplakia: A Rare Involvement in a Patient with Polycythemia Vera. [PDF]

Int J Hematol Oncol Stem Cell Res
Medeiros YL, Oliveira DMA, Júnior ARP, de Souza LLT, Pinto CAL, Jaguar GC, Alves FA.   +6 more
europepmc   +1 more source

Myocardial Infarction in Polycythemia Vera and Dengue: A Case of Competing Risks. [PDF]

Cureus
Politi MT, Vannoni G, Gagliardi J.
europepmc   +1 more source